Press releases and featured news.

Insights from leading publications and breaking news.

2 mins

The Path to Automation in the Clinical Laboratory

As clinical labs face a slew of workflow challenges—including personnel shortages and increasing pressure to reduce costs—automation is making a strong case for adoption. This technology’s affinity for completing otherwise tedious, repetitive tasks means that lab technologists and clinicians can spend more time making critical and better-informed decisions, some of which may lead to life-changing and life-saving results for patients.
Link to full article
4 min

Siemens Healthineers Enters into Agreement with Scopio Labs to Distribute Full-Field Digital Cell Morphology Technology

The alliance between Siemens Healthineers and Scopio Labs will revolutionize the way laboratorians view patient samples—from under a microscope to digitized slides. Scopio Labs has granted to Siemens Healthineers global rights to distribute the Scopio X100 and Scopio X100HT, digital solutions that offer full-field imaging and an AI-powered Decision Support System with remote viewing capabilities. Scopio Labs' groundbreaking technology complements Siemens Healthineers' existing hematology portfolio to provide more expansive end-to-end workflow solutions.
Read more
3 min

Study Reveals Faster Turnaround Time in Clinical Laboratory With Scopio Labs’ Remote Digital Morphology

Study at Tel Aviv Sourasky Medical Center is first to quantify tele-hematology's impact on laboratory performance; demonstrates more efficient workflows and decrease in costs.
Read more
3 mins

Scopio Labs Named No 1. to Fast Company’s 2023 Most Innovative Medical Device Companies List

Scopio Labs, developer of Full-Field Cell Morphology™ imaging and analysis platforms, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies list for 2023. The annual list highlights the businesses at the forefront of their respective industries and recognizes organizations that are transforming industries, shaping society, and moving the world forward.
Read more
3 mins

Scopio Labs Doubles Down on Digital Cell Morphology Go-To-Market Strategy in 2023

Scopio Labs, developer of Full-Field Digital Cell Morphology™ imaging and AI-powered analysis platforms, announced today that it will focus on the commercialization of its laboratory diagnostic solutions in 2023 to accelerate market penetration and growth. To this end, Mr. Amir Farhi has joined as the company’s first Chief Commercial Officer (CCO). Farhi brings over 30 years of experience in sales, marketing, strategic alliances and operations, and will be responsible for overseeing the development and execution of the commercial strategy of the company.
Read more
5 mins

Scopio Labs Launches World’s First Digital Application for Bone Marrow Aspirate Imaging and Review

Scopio Labs, developer of Full-Field Cell Morphology™ imaging and AI-powered analysis platforms to support laboratory professionals in the detection of cancers, anemia, infections, and other blood-related diseases, announced today the launch of the Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. This platform is the first to enable a complete digital workflow for bone marrow aspirate scanning and analysis.
Read more
3 mins

Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform

Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms.
Read more
4 mins

Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization

This is the company's second FDA clearance, broadening its suite of fully digital platforms to cater to all lab sizes and networks. Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world.
Read more
4 mins

Scopio raises $50M to take a deeper look into our blood cells

Scopio Labs, provider of the world’s first full-field digital cell morphology solution, today announced a $50M investment for its end-to-end hardware and software platform for digitizing, quantifying and analyzing hematology and other digital cytology samples. The Series C round included OurCrowd, Aurum Ventures, Mizrahi-Tefahot Bank Invest and Ilex Medical, with the participation of strategic investors operating in the field and existing investors.
Read more
4 mins

Scopio Labs Launches Full-Field Peripheral Blood Smear Application, Bringing End-to-End Digital Workflow to Hematology Labs to Transform Diagnostic Testing

Scopio Labs, provider of the world’s first full-field digital cell morphology solution, announced today the commercial launch of its FDA-cleared and CE-approved Full-Field Peripheral Blood Smear (FF-PBS) Application on the X100 platform. The application’s commercialization is an important step in the company’s plan to transform hematology and introduce a new line of digital solutions for cell morphology analysis that enable earlier detection, diagnosis and treatment for improved patient outcomes.
Read more
5 mins

Scopio Labs Receives FDA Clearance for its AI-Powered Full Field Peripheral Blood Smear (Full Field PBS) Application

The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics. Scopio Labs, a leading provider of Full Field Morphology (FFM), announced today that it was granted FDA clearance to market and sell its X100 with Full Field Peripheral Blood Smear (Full Field PBS) Application, unlocking the potential of in vitro hematology diagnosis. Full Field PBS is also available in Europe with CE mark certification granted earlier this year.
Read more